BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 7, 2018

Total Value ($000): $986,483 (100.0% shares, 0.0% debt)

Holdings (43)

CHEMOCENTRYX INC 9.9%
Value ($000) $97,938 Shares 7,201,316 Est. Cost $8.94 Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 8.7%
Value ($000) $85,519 Shares 5,542,400 Est. Cost $12.46 Unrealized 0.0%
ARRAY BIOPHARMA INC 8.4%
Value ($000) $82,624 Shares 5,062,768 Est. Cost $8.39 Unrealized
BLUEPRINT MEDICINES CORP 6.1%
Value ($000) $60,120 Shares 655,611 Est. Cost $25.16 Unrealized
ARQULE INC 4.8%
Value ($000) $47,338 Shares 16,436,912 Est. Cost $1.75 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 4.7%
Value ($000) $46,014 Shares 3,233,618 Est. Cost $9.90 Unrealized +7.3%
MERUS N V 4.5%
Value ($000) $44,832 Shares 2,419,443 Est. Cost $18.53 Unrealized
CONCERT PHARMACEUTICALS INC 4.5%
Value ($000) $44,246 Shares 1,932,123 Est. Cost $14.18 Unrealized
CYTK CYTOKINETICS INC 4.2%
Value ($000) $41,198 Shares 5,721,888 Est. Cost $10.41 Unrealized -17.7%
ANAB ANAPTYSBIO INC 4.1%
Value ($000) $40,182 Shares 386,065 Est. Cost $23.32 Unrealized +383.4%
XOMA XOMA CORP DEL 3.1%
Value ($000) $30,402 Shares 1,502,800 Est. Cost $5.35 Unrealized +422.7%
XNCR XENCOR INC 2.7%
Value ($000) $27,042 Shares 902,000 Est. Cost $26.15 Unrealized 0.0%
CTI BIOPHARMA CORP 2.7%
Value ($000) $27,026 Shares 6,929,690 Est. Cost $3.77 Unrealized
KURA KURA ONCOLOGY INC 2.6%
Value ($000) $25,385 Shares 1,353,846 Est. Cost $9.39 Unrealized +107.4%
PIERIS PHARMACEUTICALS INC 2.5%
Value ($000) $24,501 Shares 3,592,549 Est. Cost $4.16 Unrealized
BIOLINERX LTD 2.3%
Value ($000) $22,616 Shares 25,995,575 Est. Cost $1.01 Unrealized
CRVS CORVUS PHARMACEUTICALS INC 2.3%
Value ($000) $22,533 Shares 1,954,254 Est. Cost $10.04 Unrealized -5.8%
INFIQ INFINITY PHARMACEUTICALS INC 2.1%
Value ($000) $20,510 Shares 9,766,508 Est. Cost $3.23 Unrealized -33.7%
RCUS ARCUS BIOSCIENCES INC 2.0%
Value ($000) $19,606 Shares 1,269,788 Est. Cost $16.66 Unrealized 0.0%
SPRO SPERO THERAPEUTICS INC 1.5%
Value ($000) $14,948 Shares 1,048,958 Est. Cost $12.27 Unrealized -1.2%
IMMUNE DESIGN CORP 1.4%
Value ($000) $13,550 Shares 4,106,200 Est. Cost $3.51 Unrealized
ONCOMED PHARMACEUTICALS INC 1.4%
Value ($000) $13,525 Shares 4,253,189 Est. Cost $8.77 Unrealized
ERYTECH PHARMA 1.3%
Value ($000) $13,125 Shares 625,000 Est. Cost $22.02 Unrealized
SPRING BK PHARMACEUTICALS INC 1.3%
Value ($000) $12,800 Shares 832,247 Est. Cost $13.69 Unrealized
VBI VACCINES INC 1.1%
Value ($000) $10,850 Shares 3,100,000 Est. Cost $4.27 Unrealized
GTX INC DEL 1.1%
Value ($000) $10,823 Shares 609,748 Est. Cost $5.28 Unrealized
FORWARD PHARMA A/S 1.0%
Value ($000) $10,319 Shares 4,755,117 Est. Cost $8.30 Unrealized
REGULUS THERAPEUTICS INC 1.0%
Value ($000) $10,027 Shares 13,974,249 Est. Cost $1.20 Unrealized
VERASTEM INC 0.8%
Value ($000) $8,156 Shares 2,737,000 Est. Cost $3.05 Unrealized
ADURO BIOTECH INC 0.8%
Value ($000) $7,501 Shares 806,534 Est. Cost $9.30 Unrealized
ALBIREO PHARMA INC 0.7%
Value ($000) $7,328 Shares 225,000 Est. Cost $32.57 Unrealized
TOCAGEN INC 0.6%
Value ($000) $5,978 Shares 504,483 Est. Cost $12.03 Unrealized
CONTRAFECT CORP 0.6%
Value ($000) $5,565 Shares 3,500,000 Est. Cost $1.11 Unrealized
MOLECULAR TEMPLATES INC 0.6%
Value ($000) $5,509 Shares 688,629 Est. Cost $6.97 Unrealized
ALPINE IMMUNE SCIENCES INC 0.5%
Value ($000) $5,406 Shares 675,759 Est. Cost $11.60 Unrealized
GENOCEA BIOSCIENCES INC 0.5%
Value ($000) $5,250 Shares 5,000,000 Est. Cost $1.05 Unrealized
SUNESIS PHARMACEUTICALS INC 0.5%
Value ($000) $4,582 Shares 1,684,636 Est. Cost $3.60 Unrealized
XENE XENON PHARMACEUTICALS INC 0.4%
Value ($000) $3,532 Shares 720,830 Est. Cost $8.35 Unrealized -55.7%
PTGX PROTAGONIST THERAPEUTICS INC 0.4%
Value ($000) $3,484 Shares 405,600 Est. Cost $18.04 Unrealized +4.4%
VICAL INC 0.2%
Value ($000) $2,044 Shares 1,409,444 Est. Cost $1.83 Unrealized
ESSA PHARMA INC 0.2%
Value ($000) $1,935 Shares 10,183,646 Est. Cost $0.19 Unrealized
LOXO ONCOLOGY INC 0.1%
Value ($000) $506 Shares 4,386 Est. Cost $53.87 Unrealized
OREXIGEN THERAPEUTICS INC 0.0%
Value ($000) $108 Shares 534,900 Est. Cost $3.32 Unrealized